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SURGICAL ETHICS CHALLENGES
Surgeon-industry relationships: Ethically
responsible management of conflicts of interest
James W. Jones, MD, PhD,a and Laurence B. McCullough, PhDb
A representative of Medflow Corporation brings break-
fast to all of the morning surgical conferences and talks
regularly with residents and faculty. She also provides
educational travel funds to you as Chair for departmen-
tal use. Some of Medflow’s medical products are used at
your institution. What answer most accurately charac-
terizes the ethical implications of this relationship?
A. Accepting gifts from commercial sources is always
wrong within the medical profession.
B. Since you would already be using Medflow products,
there is no conflict.
C. You do not have a serious conflict of interest if you have
minimal purchasing authority and accept only minor
gifts from vendors.
D. Physicians with any influence on medical purchases are
nearly always violating their fiduciary obligations to
patients and their institutions by accepting gifts from
product manufacturers.
E. More of our educational funding must be provided by
sources other than faculty clinical practice, and com-
pany support is welcome.
Answer D best characterizes the relationship. The least
ethically defensible choices are B and E.
The surgeon’s relationship with patients is understood
in medical ethics to be fiduciary. This means that the
surgeon makes reliable judgments about the patient’s
health, promotes and protects the patient’s health as a
primary goal, and sublimates his own self interest to his
patient’s. A conflict of interest can occur even when the
surgeon’s legitimate and necessary self interest, including
concern for personal time and an adequate income, con-
flicts with his fiduciary obligation to give primacy to his
patient’s interests.1
The surgeon’s professional integrity compels him to
maintain standards of intellectual and moral excellence in
his practice. Intellectual excellence means that one’s clinical
judgment is based upon the best scientific and clinical
information available. The commitment to intellectual ex-
cellence is central to the first of the three components of
fiduciary responsibility, the reliability of the surgeon’s med-
ical decisions. A commitment to moral excellence provides
the basis for the second and third components of fiduciary
responsibility, dedication to the patient’s health and to the
primacy of his needs.
Accepting money or other gifts from medical equip-
ment and pharmaceutical manufacturers creates the poten-
tial for conflicts of interest. In a classic discourse, Waud2
called gifts from the medical industry “bribes to physicians”
because physicians order the products; they do not pay for
them. Choices B and E represent two common rationaliza-
tions for accepting these gifts and denying the element of
bribery. Choice B is unacceptable because a potential con-
flict of interest resides in the possibility that the company
gift could influence future decisions to continue purchase
of its products, even if another manufacturer makes avail-
able a model with improved patient-care features. Subtly
affected by the donation, the surgeon may even uncon-
sciously respond to a sense of future obligation toward the
company. Choice E fails to recognize that economic con-
flicts of interest can be created even in the process of
meeting real and important institutional needs for revenue
in support of medical education. The utilitarian argument
of an important unmet need does not justify an inappropri-
ate response. The unspoken obligations created by such
seemingly altruistic educational support can gain a compet-
itive advantage for the donor company unrelated to the
patient-care qualities of its products. At the very least the
gift buys product name recognition, a commodity highly
valued by manufacturers and campaigning politicians in
influencing future choices.
Choice D best addresses this multifaceted problem,
because it alerts the surgeon to the core issue of economic
conflicts of interest. Choice C fails to consider that even
though the financial value of the contribution is insubstan-
tial, the company’s intent is always to create some sense of
good will, indebtedness, or obligation that will ultimately
manifest itself in increased or continued product sales.
Physician administrators and members of pharmacy and
equipment committees are not the only ones who influence
purchases. Every physician who writes a prescription or
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suggests a new device to his clinical service chief is affecting
some company’s profitability.
Choice A, which implies severance of all financial ties
with industry, is one emphatic approach to protecting the
fiduciary integrity of an academic program or private prac-
tice. Accepting grants for scientifically sound, independent
research, and arms-length sponsorship of scientific meet-
ings can remain acceptable activities, however. Manufactur-
ers whose motivations are entirely altruistic should be en-
couraged to make their donations to our professional
programs anonymously.
Travel funds, honoraria for nominal “consultancies,”
lunch for our students and residents, elegant dinners ac-
companied by product demonstrations, and guest lecturers
with favorable views of donors’ products are all suspect, and
all threaten our integrity as well as our ability to think first
of our patients in our medical decisions. Graduate and
professional schools in other intellectual disciplines less
lavishly courted by marketers seem somehow to fulfill their
functions, after all. No one should assume that economic
conflicts of interest are benign; they are volatile and poten-
tially predatory on fiduciary integrity.
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